Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
71.5 GBX | +0.70% | +4.38% | +43.00% |
Mar. 26 | EARNINGS: CAB Payments profit drops, Life Science REIT cuts dividend | AN |
Mar. 26 | BATM Advanced ink USD2.3 million orders | AN |
Strengths
- The prospective high growth for the next fiscal years is among the main assets of the company
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Weaknesses
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
Ratings chart - Surperformance
Sector: Business Support Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+43.00% | 94.98M | - | ||
+13.36% | 87.31B | B | ||
+6.84% | 68.73B | B | ||
-4.94% | 42.87B | C- | ||
-12.53% | 28.43B | C- | ||
+7.07% | 21.51B | C+ | ||
-15.96% | 12.22B | A- | ||
-9.95% | 10.12B | C | ||
+7.63% | 8.85B | C+ | ||
-23.82% | 7.89B | B+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- TRU Stock
- Ratings TruFin plc